SyVento says bringing the FlexFactory to Poland makes new therapies available to patients in an efficient and high-quality ...

Bayer and Codone Biotechnology (Codone) signed a collaboration agreement, marking Codone the first resident company of Bayer ...

The Washington State Employment Security Department said in the filing that 72 employees will be laid off on Jan. 17. A ...

Hera Biotech is developing a less invasive, more accurate diagnostic test for endometriosis, an often painful condition that ...

Clark University in Worcester has opened a new biotechnology research laboratory after one of its professors received a $750,000 grant in support of the project. The lab, funded by a Workforce ...

Binance Labs has invested in BIO Protocol, marking its first venture into decentralized science. BIO Protocol’s BioDAO ...

Biotech startup Anthrogen secured $4 million seed funding to offer carbon-free solutions using AI, co-led by Regen Ventures ...

The potential anchor tenant, a biotech firm based in the innovation district, is being recruited by other cities.

If the United States does not lead in emerging biotechnologies, our adversaries will, writes GOP Sen. Todd Young of Indiana.

The U.S. life sciences development bubble burst at the start of 2024, and it is going to take some time simply to pick up the pieces. There are already signs of recovery for the new year, though.